Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 2,006 $ 5,343
Accounts receivable, net 2,870 4,339
Non-trade receivable 6,967 7,119
Related party receivable 181 181
Inventory 9,889 10,621
Prepaid expenses and other current assets 5,210 4,562
Total current assets 27,123 32,165
Property and equipment, net 161 227
Contract fulfillment assets 8,014 6,399
Other assets 780 948
Total assets 36,078 39,739
Liabilities and stockholders’ equity (deficit)    
Accounts payable 20,583 22,848
Accrued liabilities 12,163 20,892
Promissory note, net, current portion 2,916
Total current liabilities 35,662 43,740
Income tax payable 1,750 1,699
Total liabilities 37,412 45,439
Commitments and contingencies (Note 8)
Stockholders’ equity (deficit)    
Common stock, $0.001 par value per share; 100,000,000 shares authorized; and 10,338,905 and 4,983,868 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively 10 5
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively
Additional paid-in capital 289,281 277,903
Accumulated deficit (290,625) (283,608)
Total stockholders’ equity (deficit) (1,334) (5,700)
Total liabilities and stockholders’ equity (deficit) $ 36,078 $ 39,739